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T cell activation markers “CD45RO and CD45RA”; neutrophil CD11b 
expression and soluble tumor necrosis factor receptor (p55) in early 
diagnosis of neonatal sepsis. 
 
INTRODUCTION 
Infection is still an important cause of neonatal 
morbidity and mortality despite the development of 
broad spectrum antibiotics and technical advances 
in life support therapy1. Since outcome and 
prognosis depend on early and efficient antibiotic 
therapy, there is a need for sensitive and specific 
indicators of sepsis at the earliest stage of the 
disease2. Early signs and symptoms are often non 
specific, subtle, and can be easily confused with 
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non-infective causes such as apnea of prematurity, 
variation in environmental temperature, and acute 
exacerbation of chronic lung disease3. Laboratory 
indicators such as complete blood cell count, ratio 
of immature to total neutrophils and C-reactive 
protein (CRP) do not have high sensitivity 
especially if measured early in the course of sepsis2. 
A more reliable method for detection of 
infection may be the demonstration of activated T 
lymphocytes, which can be done rapidly and before 
isolation of the offending organism. Human T 
lymphocytes can be divided into various subsets by 
the expression of the isoforms of the leukocyte 
common antigen, CD45. The CD45RA isoform is 
brightly expressed on the newborn naive T cells. 
The CD45RO isoforms marks memory T cells, 
which respond to recall antigenic stimulation by 
proliferation.  It also provides helper activity for 
antigen-specific antibody synthesis. It is probable 
that isoform switching form CD45RA to CD45RO 
occurs in vivo in the newborn following antigenic 
stimulus by an infective organism6. Also the 
expression of surface functional antigen on 
neutrophils and their up-regulation in infection may 
be of value. Neutrophil CD11b is a promising test 
for exclusion of early onset neonatal infection4. 
Cell surface receptors for tumour necrosis 
factor (TNF) and their soluble forms, which are 
released into the circulation, are important in 
mediating and regulating the divergent TNF effects. 
Two TNF receptors with molecular masses of 55 
and 75 KDa have been cloned. The 55-KDa 
receptor mediates cytotoxic effects, up regulates 
adhesion molecules, and appears to be important for 
resisting infection by the intracellular organisms5. 
This study is aimed to evaluate the value of  up-
regulation of T lymphocyte activation markers 
CD45RA/CD45RO, CD45RO, neutrophil CD11b 
expression, and soluble tumour necrosis factor 
receptor (P55) as tests for early detection of 
neonatal sepsis in comparison to some  




The current study was conducted on 39 neonates, 
25 males (64 %) and 14 females (36 %), of whom  
15 were preterms (38 %) and 24 were full term 
babies (62 %).They were enrolled selected from the 
NICU and general nursery of the Departments of 
Pediatrics and Gynecology and Obstetrics,  Ain 
Shams University Hospitals. The studied neonates 




This group included 9 neonates at high risk for 
neonatal sepsis, but not clinically septic.  However, 
they acquired clinical signs of sepsis after a few 
days from enrollment. They were 5 males and 4 
females; 5 preterms and 4 full terms. Their ages 
ranged between 1 and 7 days (mean = 3 ± 2 days) . 
Their weight values ranged between 1.8 and 3.5 kg 
with a mean weight of 2.3 ± 2.5 kg. 
Inclusion criteria: 
1- Maternal intrapartum risk factors as unexplained 
prematurity, prolonged premature rupture of 
membranes, intrapartum fever, documented 
UTI.  
2- Cases that underwent exchange transfusion. 
3- Cases that were mechanically ventilated.  
4- Cases that underwent surgery. 
Group II: 
This group included 21 cases of neonatal sepsis (15 
males and 6 females); 7 preterms and 14 full terms. 
Their postnatal ages ranged between 3 and 40 days 
(mean = 15.28 ± 12.06 days). Their weight values 
ranged between 1.3 and 3.8 kg (mean = 2.7 ± 0.73 
kg). The neonates were diagnosed on basis of their 
history, physical examination, and laboratory 
investigations. 
Inclusion criteria: 
1- Symptoms and signs suggestive of sepsis 
(Tollner score > 10.5)4. 
2- Positive blood, urine or CSF culture.  
3- Elevated CRP. 
4- Positive Hematological sepsis score. 
Group III - Control Group: 
This group included 9 healthy neonates, 5 males 
and 4 females; 3 preterm and 6 full term babies. 
Their post-natal ages ranged between 1 and 24 days 
(mean = 3.8 ± 7.6 days). Their weights ranged 
between 1.5 and 3.4 kg with mean value of 2.44 ± 
0.64 kg. 
Study measurements: 
All neonates (cases and controls) were subjected to 
the following: 
1- Medical history taking from the parents, laying 
stress on gestational age, birth weight, mode of 
delivery, premature rupture of membranes, maternal 
perinatal fever, maternal infection e.g. UTI, fetal 
distress, isoimmunization or exchange transfusion. 
2- Clinical examination, for assessment of 
gestational age, weight, manifestations of neonatal 
sepsis as lethargy, sluggish Moro reflex, poor 
suckling, hypothermia, mottling, sclerema, 
umbilical sepsis, jaundice, respiratory distress or 
abdominal distension. 
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3- Laboratory investigations: 
Blood samples were collected on admission or the 
day after. A second sample was collected 7 days 
later from neonates still present in the NICU. 
a. Complete blood picture using coulter 
T660 (Coulter corporation, Hialeah, 
Florida, USA): two ml of venous 
blood were taken from each neonate 
on EDTA solution and differential 
count was done on Leishman stained 
peripheral blood smear. This included 
total leukocytic count (TLC), 
hemoglobin (Hb), absolute neutrophil 
count, band cell count, immature to 
total neutrophil ratio, immature to 
mature neutrophil ratio, degenerative 
changes in neutrophils and platelet 
count. Hematological scoring system 
of Rodwell et al6 was used together 
with sepsis scoring system of Tollner 
4.   
b. Quantitative C-reactive protein 
(CRP) by latex agglutination slide 
test7 .    
c. Blood culture and sensitivity test for 
aerobic and anaerobic cultures using 
sheep blood agar.  
d. Examination of CSF and culture and 
sensitivity for cases with neurological 
manifestations. 
e. Assay for T cell activation markers CD45RA/ 
CD45RO and neutrophil CD11b by flow 
cytometry (FCM) using Coulter Epics XL FCM 
(Coulter electronics, Hielaeh FL, USA). 
f. Soluble tumour necrosis factor receptor sTNFR1 
by ELISA (sTNF-R1 EASIA, Biosource, Europe 
SA). 
4- Plain chest x-ray postero-anterior view. 
Techniques: 
I- Detection of CD45RA/CD45RO and CD45RO 
by flow cytometry: 
Surface marker analysis was performed on 
peripheral blood by whole blood lysis method using 
CD4 per CP, CD45RO PE and CD45RA-FITC 
(Becton Dickinson BD San Jose, CA, USA). 
 Negative isotope-matched controls were used to 
determine the non-specific binding. Stained 
samples were evaluated on the Coulter XL flow 
cytometry and were considered positive for a 
marker (if > 20% of the cells were positive). Gating 
of CD4+ lymphocytes was achieved by collecting a 
minimum of 10,000 low side scatter events in 
fluorescence channel 3. Analysis was performed on 
a FAC Scan flow cytometer and lysis II software, 
using dot plot, contour plot, and histograms 
outputs1  
II- Detection of neutrophil CD11b by flow-
cytometry: 
Samples were drawn into prechilled tubes; all 
subsequent cell handling steps were carried out on 
ice at 4°C to minimize spontaneous up-regulation in 
vitro. Whole blood 0.1 ml anticoagulated with 
EDTA was diluted with 2.5 ml of cold staining 
medium composed of deficient RPMI 1640 
medium, 1% fetal calf serum with 1 mol/1 N-2 
hydroxy ethylpiperazine-N-2-ethane sulphonic acid 
pH 7.2 (Sigma, USA). Sodium azide was added to a 
concentration of 0.02 %. Samples were washed 
once with staining medium and then re-suspended 
in 0.5 ml of staining medium. For each sample, 100 
µl of suspension was stained for 15 minutes with 
fluorescein isothiocyanete (FITC) conjugated CD15 
(10 µl) to identify neutrophils, and with 10 µl of 
phycoerythrin conjugated CD11b mouse antihuman 
monoclonal antibodies (Becton-Dickinson, 
California, USA). Before staining FITC-conjugated, 
anti CD15 was diluted with unconjugated anti-
CD15 antibody to bring CD15 staining into mid 
range on the flow cytometry instrument (FAC scan, 
Becton-Dickinson). The instrument was adjusted so 
that fluorescence of standard leads (3.2 µm sphere 
Rainbow Fluorescent Particles; Sphertech, Inc. 
Libertyville, III) in each fluorescence channel 
would be exactly the same in each run. 
Samples were analyzed on the FAC scan with a 
threshold set in a way that only cells with the 
correct range of CD15 fluorescence for neutrophils 
were accepted as events. This threshold excludes 
erythrocytes and other leukocytes. The median 
fluorescence of neutrophil CD11b was determined 
for each sample on the basis of distribution of 
CD11b fluorescence per 30,000 cells counted and 
ranged from 1 to 475 fluorescence units7. 
III - Detection of sTNFR1 (p55): 
Soluble TNFR1 was detected by means of 
immunoenzymo-metric assay (sTNF-R1 EASIA, 
Biosource, Europe SA). 50 µl of each standard, 
control, or sample were pipetted into appropriate 
wells. 200 µl of anti-sTNF-R conjugate solution 
were pipetted into each well. They were incubated 
for 1 hour at room temperature on a horizontal 
shaker set at 700 rpm ± 100 rpm. The liquid from 
each well was aspirated. The plate was washed 3 
times by dispensing 0.4 ml of biosource wash 
solution into each well, aspirating the content of 
each well. 50 µl of chromogenic solution was put 
into each well within 15 min following the washing 
step. The plate was incubated for 15 min at room 
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temperature on a horizontal shaker set at 700 ± 100 
rpm, avoiding sunlight (one word). 200 µl of stop 
solution were put in each well. Absorbance was 
read at 450 nm and 490 nm (reference filter: 630 or 
650 nm) within 3 hours, and the results were 
calculated using a standard curve8. 
Statistical analysis:  
Data were analyzed with a computer statistical 
package V.5 (StatSoft, Tulsa, OK, USA). Numeric 
data were expressed as mean ± standard deviation. 
The significance of the difference between means 
was determined by student t test for independent 
samples and paired t test for dependent samples. 
The Mann Whittney U test was used for non-
parametric data. The Pearson r correlation 
coefficient test was used to determine the 
relationship between different quantitative 
variables. For all tests, a probability of less than 
0.05 was considered significant. 
 
RESULTS 
On performing blood culture, 76 % of the septic 
group had positive pathogens, while 24 % had 
negative blood culture. None of the high-risk group 
yielded positive blood culture. Concerning the 
causative organism, 75 % of the patients with 
positive blood culture showed gram negative 
pathogens, while 25% of them showed gram 
positive pathogens.  
The up-regulation of CD45RA/CD45RO dual 
expression and CD45RO expression on T-
lymphocytes had occurred in the septic group (table 
1). Also, the % expression of CD45RA/CD45RO 
and CD45RO was significantly high in the high-risk 
group when compared to the control group. On the 
other hand, there was no significant difference 
between CD45RA/CD45RO and CD45RO % 
expression between the studied septic group and the 
high-risk group. Also, there was no difference 
between those who died or survived in their 
baseline results (table 3). The follow up sample 
taken after 1 week showed a significant increase in 
the expression of CD45RO compared to the initial 
sample in the septic group. In the high-risk group, 
there was no significant difference between the 
initial samples and the follow up samples (table 2). 
There was no significant difference in the 
expression of CD45RA/CD45RO or CD45RO in 
the preterm septic neonates when compared to the 
full term septic neonates and there was no gender 
difference.  
CD11b expression was significantly high in 
septic group (72.8 ± 17.3%) when compared to the 
control group (17.2 ± 9.9%, p<0.05), and was 
significantly elevated in the high- risk group (42.2 ± 
25.9 %, p<0.05) as compared to the control group 
(table 1). Furthermore, there was no significant 
effect of gestational age or gender on the level 
CD11b (p>0.05). Those with positive blood culture 
have significantly higher CD11b level than those 
with negative blood culture (p< 0.05). No 
difference could be elicited between those who died 
or survived in the initial samples, or between them 
in the follow up samples. The optimal cutoff point 
obtained from ROC method was >25% expression 
with 93% sensitivity and 89% specificity (table 4).  
 
 
Table (1): Comparison between the patients and 












n = 21 
Septic 
score 
2.89 ± 1.27 8.22 ± 2.82 12.93 ± 1.85 
        p  0.0004 < 0.001 
TLC  
(× 109/L) 
7.68 ± 2.74 7.94 ± 2.29 14.06 ± 8.18 
        p  0.7239 0.0186 
PLC  
(× 109/L) 




        p  0.0092 0.0033 
Hb  
(gm / dL) 
14.41 ± 1.46 12.58 ± 3.66 11.80 ± 2.51 
        p  0.1820 0.0071 
PNL  
(× 109/L) 
4.64 ± 2.14 5.32 ± 2.26 9.92 ± 6.89 
        p  0.2697 0.0223 
Imm.  
(× 109/L) 
0.04 ± 0.06 0.16 ± 0.21 0.95 ± 1.12 
        p  0.2332 0.0012 
CRP  
(mg/dL) 
2.88 ± 1.30 2.22 ± 1.72 67.6 ± 39.8 
        p  0.29 < 0.001 
CD11b (%) 17.2 ± 9.9 42.4 ± 25.9 72.8 ± 17.3 
        p  0.0036 < 0.0001 
Dual exp 
(%) 
1.67 ± 0.46 8.36 ± 3.28 11.62 ± 6.01 
        p  0.0006 < 0.0001 
CD45RO 
(%) 
3.43 ± 0.93 11.40 ± 4.43 13.35 ± 7.81 
        p  0.0005 < 0.0001 
sTNFR1 
(ng/ml) 
6.44 ± 1.49 26.90±16.89 18.14 ± 9.38 
        p  0.0092 0.0008 
CRP= C- reactive protein , Hb= hemoglobin, Imm.= Immature 
cells, PLC = Platelet count, PNL= polymorphonuclear 
leukocytes, sTNFR1= Soluble tumour necrosis factor receptor 
1, TLC= Total leukocytic count. p≤ 0.05 = significant 
 
 
sTNFR55 was significantly high in the septic 
(18.14± 9.38 ng/ml) as well as in the high risk 
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groups (26.90 ±16.89 ng/ml) when compared to the 
control group (6.44 ±1.49 ng/ml) (p<0.05) with no 
significant difference between the former two 
groups when compared together (p>0.05) (table 1). 
No effect of gestational age or gender on the level 
of sTNFR55 in all studied neonates was observed. 
Also, there was no significant difference between 
the initial samples and the follow up samples 
(p>0.05) (table 3), and between survivors and non -
survivors whether initially or in the follow up 
samples (p>0.05) as far as was concerned (table 2). 
The cutoff point obtained by ROC method was 8.4 
ng/ml with sensitivity of 80% and specificity of 
100% (table 4).    
CRP was significantly high in the septic group 
when compared to the control group (p<0.05). In 
the high risk group, CRP was negative initially, 
which turned positive with the appearance of signs 
and symptoms of infection. It had a sensitivity of 
70% and a specificity of 100% (table 4). 
CD11b was positively correlated to both 
CD45RA/CD45RO and CD45RO in neonatal 
sepsis. At the same time, it was found to hold a 
positive correlation with sTNFR1 in the same 
group. On attempting to correlate 
CD45RA/CD45RO to CD45RO, a positive 




Table (2): Comparison  between the initial 
samples and the follow up samples of the septic 
neonates in the studied variables. 
 Initial 
n = 9  
Mean ± SD 
Follow-up 
n = 9  
Mean ± SD 
 
p 
Septic score 10.94 ± 4.25 12.00 ± 2.32 0.496
5 
TLC (×109/L) 13.90 ± 6.40 12.41 ± 8.56 0.857
2 






Hb (gm/dL) 12.93 ± 3.69 9.69 ± 2.80 0.013
8 
PNL (×109/L) 9.83 ± 6.40 9.48 ± 7.92 0.764
2 
Imm. (×109/L) 0.92 ± 1.14 0.48 ± 0.25 0.441
3 


















Dual       (%) 10.30 ± 8.11 3.89 ± 3.26 0.085
4 
sNFR1(ng/ml) 21.90 ± 
12.22 
18.36 ± 9.86 0.477
7 
CRP= C- reactive protein , Hb= hemoglobin, Imm.= Immature 
cells, PLC = Platelet count, PNL= polymorphonuclear 
leukocytes, sTNFR1= Soluble tumour necrosis factor 
receptors, TLC= Total leukocytic count. p≤ 0.05 = significant 
 
Table (3): Comparison between survivors and 




n = 15 
Survivors 
 
n = 15 
 
p 













































CRP= C- reactive protein , Hb= hemoglobin, Imm.= Immature 
cells, PLC = Platelet count, PNL= polymorphonuclear 
leukocytes, sTNFR1= Soluble tumour necrosis factor 
receptors, TLC= Total leukocytic count. p≤ 0.05 = significant 
 
Table (4): Results of ROC analysis for 
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0 
 - 9 30 9 100   
AUG = Area under the ROC curve; CI = Confidence interval, 
sTNFR1= Soluble tumour necrosis factor receptors SE = 
Standard error; * Significant Optimal cut-oft (highest 
sensitivity & specificity) is obtained from the ROC (receiver-
operator characteristic) curve. 
DISCUSSION 
On comparing the laboratory data between the 
septic and control neonates, it was found that the 
hemoglobin (Hb) level was significantly lower in 
the septic group and that 71% of that septic group 
showed thrombocytopenia (PLT <150 × 109/L) 
compared to 55% of the high-risk group. There was 
a significant increase in the total leukocytic counts 
(TLC) of the septic neonates as compared to the 
control group while no such difference could be 
elicited when comparing the high-risk group to the 
controls. In the mean time, 48 % of the septic group 
showed absolute neutrophilia (>7.5 × 109/L) with 
57% absolute immature forms (>0.4 × 109/L) 
compared to values of  11% and 11% respectively 
in the high-risk group. Thus, on applying the 
hematological scoring system (HSS) of Rodwell et 
al 6 to cases and controls, 61% of the septic group 
had scores ≥3 (positive) compared to  11% of the 
high-risk group. Manucha et al. 9 reported that a 
hematological score ≥3 had a sensitivity of 86% and 
negative predictive value of 96%, thus permitting 
an objective assessment of hematological changes 
that occur in a neonate suspected to have sepsis.  
C-reactive protein (CRP) was found to be 
significantly high in the septic as compared to the 
control group. The high-risk group had negative 
CRP initially, which turned positive on appearance 
of signs and symptoms of infection. CRP was found 
to have a sensitivity of 70% and specificity of 
100%. This was in agreement with Kuster et al 2 
who stated that CRP is of a low sensitivity 
especially if measured early in the course of sepsis, 
but CRP concentrations increase later in the course 
of sepsis. Nuntnarumit et al 10 reported that serial 
CRP gave very high predictive values for diagnosis 
of neonatal sepsis. 
The current study revealed that up-regulation of 
CD45RA/CD45RO dual expression and CD45RO 
expression on T-lymphocytes had occurred in the 
septic group. This was in agreement with Hodge et 
al1 who found that in all cases of infection, 
confirmed by bacterial culture or viral serology, up-
regulation of either CD45RA/ CD45RO or 
CD45RO on CD4+ T-lymphocytes had occurred. 
Concurrently, the % expression of 
CD45RA/CD45RO and CD45RO was significantly 
high in the high-risk group when compared to the 
control group with no significant difference 
between their expression among the septic and 
high-risk groups. Hodge et al 1 stated that 
CD45RA/CD45RO co-expression is a very early 
activation marker, whose enhanced expression can 
be detected in early stages of infection, before up-
regulation of the CD45RO isoform. On attempting 
to correlate CD45RA/CD45RO to CD45RO, a 
positive association was found. This can be 
explained by the dual positive expression of 
CD45RA/CD45RO after stimulation of 
lymphocytes before conversion to single CD45RO 
isoform1. 
There was no difference in the base line levels 
of T-lymphocyte activation markers between those 
who died or survived. However, the follow up 
samples taken 1 week later showed a significant 
increase in the expression of CD45RO than the 
initial samples of the septic group. This was in 
contrast to what was reported by Field et al 11 who 
found that non-survivors had lower CD45RO than 
survivors of sepsis. They explained their finding by 
immunological immaturity of infants as a result of 
low numbers of CD45RO+ (memory/antigen-
primed) T-cells. The activated T-cells in infants 
with confirmed bacterial infection in their series 
persisted for several weeks and returned to normal 
ranges within 4-6 weeks. 
There was no variation in the expression of 
CD45RA/CD45RO or CD45RO with gestational 
age or gender. This was in agreement with Hodge et 
al 1 who stated that prematurity had no effect on the 
up-regulation of CD45RA/ CD45RO or 
CD45RO.There was no significant difference 
between cases with positive and those with negative 
hematological sepsis scores in the expression of 
CD45RA / CD45RO and CD45RO. On the other 
hand, their co-expression was found to be 
significantly higher in those with sepsis confirmed 
by blood culture. Weirich et al 12 found no 
significant relationship between white blood cell 
sub-population counts (e.g., segmented neutrophils, 
immature neutrophils, lymphocytes) and positive 
cultures, clinical signs of infection or CRP status. In 
our series, CD45RA/CD45RO had a 97% 
sensitivity and 100% specificity with a cut-off value 
>2.2% expression. Similarly, CD45RO had a 97% 
sensitivity and 100% specificity with a cut-off value 
>5% expression. This confirms or matches the 
results given by Hodge et al 1 who stated that the 
predictive value of the test was upheld by results 
which showed that 100% of infants with confirmed 
infection demonstrated increased expression of 
CD45RA/CD45RO or CD45RO.  
CD11b expression was found significantly 
higher in the high-risk than the control group and 
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was significantly higher in the septic when 
compared to the high-risk group. The same finding 
was previously reported by El-Kerdani et al 7 who 
added that CD11b was elevated in neonates with 
proven infection and in nearly all neonates in whom 
clinical signs suggested sepsis and its expression 
increased rapidly after the onset of sepsis, before 
rise in serum concentration of CRP, the most 
commonly used marker for infection. 
No significant influence of gestational age or 
gender could be noted on the level of CD11b 
elevation. The same observation was made by 
Nupponen et al 13 who reported that there was no 
association between birth weight or gestational age 
and the level of CD11b expression. The same 
finding was also demonstrated by El-Kerdani et al 7, 
denoting that even the premature infant can express 
CD11b. Moreover, the neonates with positive 
hematological septic scores did not differ from 
those with negative scores in the expression of 
CD11b. On the other hand, septic cases with 
positive blood culture had significantly higher 
CD11b levels than culture negative cases. Weirich 
et al12 similarly reported that there was no 
significant relationship between the white blood 
cell sub-population counts (segmented neutrophils, 
immature neutrophils, lymphocytes) and levels of 
CD11b. Nupponen et al13 also  found a two to four 
fold increase in neutrophil CD11b expression in 
infants with blood culture positive sepsis. 
There was no difference between those who 
died or survived in the initial samples, or between 
them in the follow up samples as far as the 
expression of neutrophil CD11b was concerned. 
Also, there was no significant difference between 
the initial and follow up sample taken after 1 week 
in each group.  Muller et al14 reported that poor 
prognosis is associated with a lower expression of 
activation markers on neutrophils, suggesting that 
poor outcome may be due to compensatory anti-
inflammatory response. Neutrophil CD11b had a 
sensitivity of 93% and a specificity of 89% with a 
cut off value >25% expression. Weirich et al 12 
reported negative and positive predictive values, 
sensitivity and specificity for CD11b of 100%, 
99%, 96% and 100% respectively, whereas 
Nupponen et al13 reported a sensitivity of 100% and 
a specificity of 100%. 
Soluble TNF-α receptors (sTNFRs) are soluble 
proteins shed from target cells during experimental 
endotoxemia and clinical sepsis15. The soluble 
receptor (p55) was detected in serum from all term 
and preterm neonates in this study whether infected 
or not. However, its level was significantly higher 
in the septic as well as in the high-risk groups when 
compared to control group. On the other hand, no 
significant difference between the levels of 
sTNFR1 in the former two groups was detected. 
Maymon et al 16 reported that levels of sTNFRs  
increase in maternal serum and in amniotic fluid 
during pregnancy and labour, and increased 
shedding of sTNFRs may be a regulatory 
mechanism of cytokine activity during pregnancy 
and labour. Similar results were obtained by El-
Kerdani et al 7 who found that sTNFR1 level was 
significantly high in septic neonates. No effect of 
gestational age or gender on the level of sTNFR1 in 
the septic and high-risk groups was encountered in 
our study. Similar findings were reached by 
Doellner et al17 on comparing preterm and full term 
infected neonates.  
In this study, no significant difference was 
found between the mean level of sTNFR1 measured 
initially and one week later or between its level in 
survivors and non survivors, whether initially or by 
follow up. Doellner et al 18 stated that the levels of 
sTNFR p55 seemed to decrease as time passed after 
delivery (whether infected or not). These time-
related changes in sTNFRs levels may be due to a 
physiological elimination or may be due to the 
effect of antibiotics. The cases with positive 
hematological scores did not differ significantly 
from those with negative scores in the level of 
sTNFR p55 neither did those with positive or 
negative blood cultures. sTNFR1 was found to have 
a sensitivity of 80% and a specificity of 100% for a 
cut-off value > 8.4 ng/ml. This was in discordance 
with Doellner et al 18 who reported a sensitivity of 
70% and a specificity of only 65% for a cut off 
level of 8 ng/ml while Messer et al 19 reported a 
sensitivity of 75% and specificity of 69% for a cut 
off level of 6 ng/ml. 
CD11b was positively correlated in our series 
to both CD45RA/CD45RO and CD45RO. When 
"naive" CD45RA+ T-lymphocytes are activated by 
inflammatory processes such as infection, CD45RO 
is up-regulated and CD45RA is down-regulated1 
and neutrophil CD11b up-regulation occurs on 
stimulation by pathogens or their products. At the 
same time, CD11b was found to have a positive 
correlation with sTNFR1 in the septic group. 
Neutrophils are known to increase their expression 
of CD11b on stimulation with TNF-α in vivo and in 
vitro12. CD11b was found to have a positive 
correlation with CRP levels in the septic group. 
Mehr et al 20 stated that TNF-α together with IL-6 
induce CRP synthesis in the liver.  
To conclude, the surface activation markers of 
T-lymphocytes (CD45RA/CD45RO and CD45RO), 
the neutrophil activation marker (CD11b) and the 
T cell activation markers in neonatal sepsis. 
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soluble TNF receptor 1 can be useful early 
indicators of neonatal sepsis, and might be superior 
to the hematological scoring system and CRP in the 
detection of neonatal sepsis at its early stages.  
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